Abstract
Background
Hemifacial spasm (HFS), an involuntary movement disorder characterized by unilateral spasms of the muscles innervated by the facial nerve, is likely to cause social anxiety disorder due to its significant facial disfigurement and may have a significant influence on a patient’s health-related quality of life (HRQoL). The goal of this study was to investigate the influence of microvascular decompression (MVD) on the severity of social anxiety symptoms and HRQoL in patients with HFS.
Methods
Patients who underwent MVD from January to May 2015 were included in this study. Demographic data were collected before surgery. Clinical data, including the standardized measures of anxiety and depression (Hospital Anxiety Depression Scale, HADS), social anxiety (Liebowitz Social Anxiety Scale, LSAS), and the severity of HFS were assessed before surgery and 6 months after surgery. HRQoL data were also collected before surgery and 6 months after surgery using the Korean version of the short form 36 (SF-36).
Results
Six patients (21.4 %) scored 60 or greater on the preoperative LSAS and were considered to have generalized social anxiety disorder (high-LSAS group). The duration of symptom was significantly higher in the high-LSAS group than in the low-LSAS group (7.8 ± 2.2 vs. 4.1 ± 2.6; p = 0.011). The high-LSAS group was more likely to have psychological comorbidities and had a more impaired quality of life than the low-LSAS group at preoperative evaluation. Six months after MVD, a significant improvement, compared to preoperative scores, was observed for the total LSAS score (p = 0.007) and anxiety subscale score of HADS (p = 0.012) in the high-LSAS group. Other significant improvements were also observed in role-emotional (p = 0.039) and mental component summary (p = 0.024) of the SF-36 in the high-LSAS group compared to the low-LSAS group.
Conclusions
This study shows that HFS patients seem to gain benefits from MVD not only for their facial disfigurement but also for social anxiety symptoms that may be associated with mental health improvements in their quality of life.
Similar content being viewed by others
References
Au WL, Tan LCS, Tan AKY (2004) Hemifacial spasm in Singapore: clinical characteristics and patients’ perceptions. Ann Acad Med Singapore 33:324–328
Jannetta PJ, Abbasy M, Maroon JC, Ramos FM, Albin MS (1977) Etiology and definitive microsurgical treatment of hemifacial spasm: operative techniques and results in 47 patients. J Neurosurg 47:321–328
Felício AC, de Oliveira G-JC, Borges V, de Azevedo Silva SM, Ferraz HB (2008) Bilateral hemifacial spasm: a series of 10 patients with literature review. Parkinsonism Relat Disord 14:154–156
Miwa H, Mizuno Y, Kondo T (2002) Familial hemifacial spasm: report of cases and review of literature. J Neurol Sci 193:97–102
Rosso A, Mattos J, Fogel L, Novis S (1994) Bilateral hemifacial spasm. Mov Disord 9:236–237
Tan E, Jankovic J (1999) Bilateral hemifacial spasm: a report of five cases and a literature review. Mov Disord 14:345–349
Ozel‐Kizil ET, Akbostanci MC, Ozguven HD, Atbasoglu EC (2008) Secondary social anxiety in hyperkinesias. Mov Disord 23:641–645
Kessler R (2003) The impairments caused by social phobia in the general population: implications for intervention. Acta Psychiatr Scand 108:19–27
Schneier FR (2006) Social anxiety disorder. N Engl J Med 355:1029–1036
Bez Y, Coskun E, Erol K, Cingu AK, Eren Z, Topcuoglu V, Ozerturk Y (2009) Adult strabismus and social phobia: a case-controlled study. J AAPOS 13:249–252
Bez Y, Yesilova Y, Kaya MC, Sir A (2011) High social phobia frequency and related disability in patients with acne vulgaris. Eur J Dermatol 21:756–760
Gundel H, Wolf A, Xidara V, Busch R, Ceballos-Baumann AO (2001) Social phobia in spasmodic torticollis. J Neurol Neurosurg Psychiatry 71:499–504
Schneier FR, Barnes LF, Albert SM, Louis ED (2001) Characteristics of social phobia among persons with essential tremor. J Clin Psychiatry 62:367–372
Stein MB, Baird A, Walker JR (1996) Social phobia in adults with stuttering. Am J Psychiatry 153:278–280
Topcuoglu V, Bez Y, Bicer DS, Dib H, Kuscu MK, Yazgan C, Gunal DI, Goktepe E (2006) Social phobia in essential tremor. Turk Psikiyatri Derg 17:93–100
Chung SS, Chang JH, Choi JY, Chang JW, Park YG (2001) Microvascular decompression for hemifacial spasm: a long-term follow-up of 1,169 consecutive cases. Stereotact Funct Neurosurg 77:190–193
Heuser K, Kerty E, Eide P, Cvancarova M, Dietrichs E (2007) Microvascular decompression for hemifacial spasm: postoperative neurologic follow‐up and evaluation of life quality. Eur J Neurol 14:335–340
Ray DK, Bahgat D, McCartney S, Burchiel KJ (2010) Surgical outcome and improvement in quality of life after microvascular decompression for hemifacial spasms: a case series assessment using a validated disease-specific scale. Stereotact Funct Neurosurg 88:383–389
Tan EK, Fook-Chong S, Lum SY, Lim E (2004) Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30). J Neurol Sci 219:151–155
Kang JH, Lee JA, Oh KS, Lim SW (2013) Validation and clinical efficacy of the Korean Liebowitz Social Anxiety Scale: clinician administered. Korean J Clin Psychol 32:291–312
Mennin DS, Fresco DM, Heimberg RG, Schneier FR, Davies SO, Liebowitz MR (2002) Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale. J Anxiety Disord 16:661–673
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370
Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the hospital anxiety and depression scale: an updated literature review. J Psychosom Res 52:69–77
Ware JE, Gandek B (1998) Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. J Clin Epidemiol 51:903–912
Dias FM, Doyle F, Kummer A, Cardoso F, Fontenelle LF, Teixeira AL (2010) Frequency of psychiatric disorders in blepharospasm does not differ from hemifacial spasm. Acta Neuropsychiatr 22:223–227
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62:593–602
Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Bobes J, Beidel DC, Ono Y, Westenberg HG (1998) Consensus statement on social anxiety disorder from the international consensus group on depression and anxiety. J Clin Psychiatry 59(Suppl 17):54–60
Asakura S, Inoue S, Sasaki F, Sasaki Y, Kitagawa N, Inoue T, Denda K, Ito M, Matsubara R, Koyama T (2002) Reliability and validity of the Japanese version of the Liebowitz Social Anxiety Scale. Seishin Igaku 44:1077–1084
Bobes J, Badia X, Luque A, Garcia M, Gonzalez M, Dal-Re R (1999) Validation of the Spanish version of the Liebowitz Social Anxiety Scale, social anxiety and distress scale and Sheehan disability inventory for the evaluation of social phobia. Med Clin (Barc) 112:530–538
Yao S, Fanget F, Albuisson E, Bouvard M, Jalenques I, Cottraux J (1998) Social anxiety in patients with social phobia: validation of the Liebowitz Social Anxiety Scale: the French version. Encéphale 25:429–435
Rytwinski NK, Fresco DM, Heimberg RG, Coles ME, Liebowitz MR, Cissell S, Stein MB, Hofmann SG (2009) Screening for social anxiety disorder with the self-report version of the Liebowitz Social Anxiety Scale. Depress Anxiety 26:34–38
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No funding was received for this research.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Rights and permissions
About this article
Cite this article
Kim, Y.G., Jung, N.Y., Kim, M. et al. Benefits of microvascular decompression on social anxiety disorder and health-related quality of life in patients with hemifacial spasm. Acta Neurochir 158, 1397–1404 (2016). https://doi.org/10.1007/s00701-016-2822-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-016-2822-4